Business Wire

Malaysia Digital Economy Corporation and Ant International Deepen Partnership to Accelerate Digitalisation of MSMEs Across Malaysia

3.12.2025 07:00:00 CET | Business Wire | Press Release

Share

The Malaysia Digital Economy Corporation (MDEC) and Ant International are strengthening their partnership to accelerate the digital transformation of micro, small and medium enterprises (MSMEs) nationwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202701220/en/

(L-R) Chen Leiming, Senior Vice President & Chief Sustainability Officer of Ant International; Ir. Wan Murdani Wan Mohamad, Vice President of Digital Adoption, MDEC; Ian Cheong, CEO of EPOS

In a newly established Memorandum of Understanding (MoU), Ant International will empower local MSMEs through EPOS, the all-in-one SME transformation platform of Ant International’s Antom, offering a comprehensive suite of digitalisation solutions. MDEC will support the programme by engaging the MSME community, industry associations, and ecosystem partners to drive broad-based digital adoption across the country.

This builds on MDEC’s ongoing collaboration with Ant International to support local talent and innovation development through its global digital business centre in Kuala Lumpur under the Business Digitalisation Initiative (BDI).

Anuar Fariz Fadzil, CEO of MDEC said, “Digitalisation has become a fundamental requirement for MSMEs to stay competitive and resilient. Our deepened collaboration with Ant International directly supports Malaysia’s journey towards an AI Nation, ensuring that even the smallest enterprises can access modern, AI-enabled tools. By synergising global technology capabilities with Malaysia’s national priorities, we are empowering MSMEs to transform how they operate, strengthen their business foundations, and participate fully in the opportunities of the digital economy.”

Driving Digital Inclusion for Malaysian MSMEs

MSMEs represent the backbone of Malaysia’s economy, accounting for 97% of all business establishments. Yet many still face challenges in adopting digital tools due to limited access, cost barriers, and lack of technical knowledge.

This collaboration is designed to bridge those gaps. Through EPOS, Ant International will unify its ecosystem of digital solutions and cutting-edge AI technologies, into a single platform that integrates payments, digital banking solutions, and growth tools tailored for MSMEs. With EPOS, MSMEs will gain access to simple, affordable, and powerful digital solutions—including payments, multi-channel online store deployment, operations management, and AI-powered productivity tools—all accessible within minutes.

Merchants can also unlock valuable business insights that enables them to run operations more efficiently, make data-driven decisions, and expand their reach across online channels.

Retail and F&B merchants stand to gain significantly. These sectors continue to face rising labour costs, manpower constraints, and increasing customer expectations for seamless, digitally enhanced experiences. As consumer behaviour shifts toward mobile-first engagement, digitalisation is no longer optional, but it is essential for sustained competitiveness and growth.

Ian Cheong, CEO of EPOS, said: “Malaysian MSMEs are ambitious, resilient, and eager to grow, but they need the right tools to compete in an increasingly digital economy. MDEC has made great strides in supporting MSME digitalisation, and through EPOS, we can advance this national strategy even further. By making advanced technology accessible within minutes, so that even the smallest business can operate smarter, serve customers better, and scale with confidence, we can ensure no MSME is left behind.”

Leveraging Malaysian Ecosystems for Support

As the agency leading Malaysia’s transformation towards an innovation-led digital economy, MDEC will spearhead initiatives to connect local communities, industry partners and ecosystem players, enabling them to collectively reach SMEs across diverse sectors.

These initiatives will include workshops and training sessions to raise awareness and facilitate access to new technologies such as AI, co-developed programs to engage SMEs and support them in adopting digital solutions, and strategic alignment of the partnership with MDEC’s broader national digitalisation strategies and ongoing initiatives.

###

About MDEC

The Malaysia Digital Economy Corporation (MDEC) was established in 1996 to spearhead the country’s digital economy. MDEC launched Malaysia Digital (MD), a national strategic initiative aimed at addressing current key challenges in the digital landscape for a robust and agile digital economy. As an agency under the Ministry of Digital, MDEC drives the digital economy through industry development, trade facilitation and policy advocacy. Visit our website at www.mdec.com.my

About Ant International

With headquarters in Singapore and main operations across Asia, Europe, the Middle East and Latin America, Ant International is a leading global digital payment, digitisation and financial technology provider. Through collaboration across the private and public sectors, Ant International’s unified techfin platform supports financial institutions and merchants of all sizes to achieve inclusive growth through a comprehensive range of cutting-edge digital payment and financial services solutions. To learn more, please visit https://www.ant-intl.com/

About EPOS

EPOS is a leading Point-of-Sale (POS) digital solutions provider based in Singapore. Supporting Ant International's mission to empower SMEs, EPOS leverages Antom’s digital capabilities as the organisation’s central hub to serve regional small and medium-sized businesses with integrated O2O digital, payment and banking solutions. For more information about EPOS, please visit https://www.epos.com.sg

View source version on businesswire.com: https://www.businesswire.com/news/home/20251202701220/en/

Contacts

Media Contact:
Ant International PR
pr@ant-intl.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye